Pharmaceutical News

RSS

Shopping abroad for cheaper medication? Here’s what you need to know

In its effort to temper the sky-high prices Americans pay for many vital medications, the Trump administration last month unveiled a plan that would legalize the importation of selected prescription drugs from countries where they sell for far less.

22 Aug 2019

Research explains why many psychiatric drugs that work in the lab don’t work in people

Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer’s disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.

22 Aug 2019

FDA clears its IND for new immunotherapeutic for treating prostate cancer

Calibr, the drug development division of Scripps Research, announced today that the U.S. Food and Drug Administration has cleared its investigational new drug application for CCW702, a novel immunotherapeutic for the treatment of patients with metastatic castration-resistant prostate cancer.

21 Aug 2019

Drug that treat human breast cancer might also work for canine lung cancer

Despite those velvet paintings of poker-playing dogs smoking pipes, cigars and cigarettes, our canine friends really don't use tobacco. But like many humans who have never smoked, dogs still get lung cancer.

21 Aug 2019

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor activating mutations.

20 Aug 2019

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

SLU researchers receive $2.1 million to find non-addictive pain medications

Neuropathic pain affects between 15 and 20 million people in the U.S. This type of pain can occur after injuries to the nervous system due to trauma, disease or exposure to neurotoxins, including after chemotherapy.

19 Aug 2019

Researchers find biological system that manages cells' response to opioid drug exposure

A team at Scripps Research in Florida has discovered a biological system that manages cells' response to opioid drug exposure. The unexpected discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications.

19 Aug 2019

Hospital pharmacist-led approach can reduce antibiotic use

In small, community hospitals that don't have resources for a dedicated staff to oversee the proper use of antibiotics, turning to staff pharmacists showed promise in a model study conducted by Duke Health.

18 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

Among hurdles for those with opioid addictions: Getting the drug to treat it

Louis Morano knew what he needed, and he knew where to get it. He made his way to a mobile medical clinic parked on a corner of Philadelphia's Kensington neighborhood, in the geographical heart of the city's overdose crisis. People call it "the bupe bus."

16 Aug 2019

Targeted pancreatic cancer drug shows promise in clinical trials

Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.

16 Aug 2019

Study finds no harm to newborns from opioid maintenance treatment during pregnancy

A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.

16 Aug 2019

MRI scans show how ADHD medication affects brain structure in children

MRI scans have revealed that children taking the medication methylphenidate experience alterations in the distribution of white matter in the brain.

15 Aug 2019

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).

15 Aug 2019

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Effects of common anti-inflammatory drug and its degradation products on amphibians

A new study in Environmental Toxicology and Chemistry takes a harder look at the effects a common anti-inflammatory medication and its degradation products have on amphibians.

13 Aug 2019

Encapsulating two drugs in same nanovector can greatly improve drug delivery

Encapsulating two drugs with different properties into nanovesicles surrounded by antibodies can greatly improve their delivery and efficacy, according to a study led by Xavier Fernández Busquets, director of the joint Nanomalaria unit at the Institute for Bionengineering of Catalonia and the Barcelona Institute for Global Health, an institution supported by "la Caixa"

9 Aug 2019

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

The use of prescription stimulants by those without medically diagnosed conditions marks a growing trend among young adults – particularly college students seeking a brain boost.

9 Aug 2019

Researchers test new drug to treat patients with chylomicronemia syndrome

People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase.

9 Aug 2019

Pharmaceutical News

Shopping abroad for cheaper medication? Here’s what you need to know

Research explains why many psychiatric drugs that work in the lab don’t work in people

FDA clears its IND for new immunotherapeutic for treating prostate cancer

Drug that treat human breast cancer might also work for canine lung cancer

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

SLU researchers receive $2.1 million to find non-addictive pain medications

Researchers find biological system that manages cells' response to opioid drug exposure

Hospital pharmacist-led approach can reduce antibiotic use

FDA approves new drug to treat patients with myelofibrosis

Among hurdles for those with opioid addictions: Getting the drug to treat it

Targeted pancreatic cancer drug shows promise in clinical trials

Study finds no harm to newborns from opioid maintenance treatment during pregnancy

MRI scans show how ADHD medication affects brain structure in children

FDA approves effective new treatment for extremely drug-resistant tuberculosis

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

Effects of common anti-inflammatory drug and its degradation products on amphibians

Encapsulating two drugs in same nanovector can greatly improve drug delivery

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

Researchers test new drug to treat patients with chylomicronemia syndrome

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News